SinoMab BioScience Limited (stock code: 3681.HK) is a Hong Kong based clinical-phase biopharmaceutical company focus on the development of novel and high-value recombinant therapeutic proteins for treating various life-threatening and debilitating diseases in human.

Biotechnology

Health Care

Life Sciences

SinoMab BioScience Ltd.

Shui On Leung

Ming Hon Yau

Guolin Xu

Shanchun Wang

Jianping Hua

The Directors team at SinoMab BioScience Ltd. oversees critical functions including process development, quality control, production, marketing, and clinical and regulatory affairs. Each director ensures their department aligns with the company’s strategic objectives to advance the development and commercialization of innovative therapeutic proteins.

Directors

The Leadership Team at SinoMab BioScience Ltd. is responsible for strategic decision-making, overseeing company operations, and driving growth. This team formulates and executes business strategies, manages financial planning, and oversees clinical and commercial activities to advance the development of novel therapeutic proteins.

SinoMab BioScience Ltd.

Org chart

Teams

Directors

Leadership Team

Offices

SinoMab BioScience Ltd.

Org chart

Teams

Directors

Leadership Team

Offices

Related companies